Key result
Hypertrophic cardiomyopathy patients with LVH had smaller end-diastolic volumes and worse global longitudinal strain than healthy controls.
Cross-Sectional (n=360)
In hypertrophic cardiomyopathy, smaller cardiac volumes explain the preserved ejection fraction despite impaired global longitudinal strain, with subtle volumetric and systolic changes present even before the development of hypertrophy.
Answers are grounded in this paper and cite their sources.
Smaller LV volumes may preserve EF despite reduced strain in HCM; extends characterization of systolic function across LVH+ and LVH− genotypes.
Objective We explored cardiac volumes and the effects on systolic function in hypertrophic cardiomyopathy (HCM) patients with left ventricular hypertrophy (HCM LVH+) and genotype-positive patients without left ventricular hypertrophy (HCM LVH−). Methods We included 180 HCM LVH+, 100 HCM LVH− patients and 80 healthy individuals. End-Diastolic Volume Index (EDVI), End-Systolic Volume Index (ESVI) and ejection fraction (EF) were assessed by echocardiography. Left ventricular (LV) global longitudinal strain (GLS) was measured by speckle tracking echocardiography. Results EDVI and ESVI were significantly smaller in HCM LVH+ compared with HCM LVH− patients (41±14 mL/m 2 vs 49±13 mL/m 2 and 16±7 mL/m 2 vs 19±6 mL/m 2 , respectively, both p<0.001) and in healthy individuals (41±14 mL/m 2 vs 57±14 mL/m 2 and 16±7 mL/m 2 vs 23±9 mL/m 2 , respectively, both p<0.001). HCM LVH− patients had significantly lower EDVI and ESVI compared with healthy individuals (49±13 mL/m 2 vs 57±14 mL/m 2 and 19±6 mL/m 2 vs 23±9 mL/m 2 , both p<0.001). EF was similar (61%±7% vs 60%±8% vs 61%±6%, p=0.43) in the HCM LVH+, HCM LVH– and healthy individuals, despite significantly worse GLS in the HCM LVH+ (−16.4%±3.7% vs −21.3%±2.4% vs −22.3%±3.7%, p<0.001). GLS was worse in the HCM LVH− compared with healthy individuals in pairwise comparison (p=0.001). Decrease in ESVI was closely related to EF in HCM LVH+ and HCM LVH− (R=0.45, p<0.001 and R=0.43, p<0.001) as expected, but there was no relationship with GLS (R=0.02, p=0.77 and R=0.11, p=0.31). Increased maximal wall thickness (MWT) correlated significantly with worse GLS (R=0.58, p<0.001), but not with EF (R=0.018, p=0.30) in the HCM LVH+ patients. Conclusion HCM LVH+ had smaller cardiac volumes that could explain the preserved EF, despite worse GLS that was closely related to MWT. HCM LVH− had reduced cardiac volumes and subtle changes in GLS compared with healthy individuals, indicating a continuum of both volumetric and systolic changes present before increased MWT.
No takes yet. Share an insight, caveat, or question.
Håland et al. (2017) conducted a cross-sectional in Hypertrophic cardiomyopathy (n=360). Hypertrophic cardiomyopathy vs. Healthy individuals was evaluated on End-Diastolic Volume Index (EDVI) (p=<0.001). Hypertrophic cardiomyopathy patients with LVH had smaller end-diastolic volumes and worse global longitudinal strain than healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: